BridgeBio Pharma Asset Turnover Growth & History (BBIO)

BridgeBio Pharma's asset turnover was 0.54 for fiscal 2025.

View full BridgeBio Pharma company overview

BridgeBio Pharma annual asset turnover history

BridgeBio Pharma annual asset turnover

Fiscal yearPeriod endedAsset turnoverChangeGrowth
20252025-12-310.540.24+78.74%
20242024-12-310.300.29+1803.08%
20232023-12-310.02−0.08−83.24%
20222022-12-310.090.01+16.86%
20212021-12-310.080.07+557.48%
20202020-12-310.01−0.06−83.30%
20192019-12-310.07

BridgeBio Pharma asset turnover trends

Over the last five fiscal years, BridgeBio Pharma's asset turnover increased from 0.01 to 0.54, a change of 0.53. The latest reported quarter, Q2 2026, shows 0.62.

About the metric

What asset turnover means

Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.

Calculation and source

How asset turnover is calculated

TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BridgeBio Pharma source filings ↗

Community posts

It’s quiet here.

No posts about BBIO yet. Start the conversation.

Write the first post